Sacubitril/valsartan eligibility and outcomes in the ESC HFA EORP Heart Failure Long-Term Registry: bridging between the PARADIGM-HF trial, ESC Guidelines and real-world
Royal Brompton and Harefield Hospital, London (United Kingdom of Great Britain & Northern Ireland)
2
presentations
0
follower
10
more
presentations
in this session
Prospective evaluation of natriuretic peptide based referral of chronic heart failure patients in primary care (PREFER): a pragmatic real world intervention study